Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Change in Cash: 2019-2025

Historic Change in Cash for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Sep 2025 value amounting to $100.9 million.

  • Harmony Biosciences Holdings' Change in Cash rose 44.07% to $100.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $259.6 million, marking a year-over-year increase of 313.53%. This contributed to the annual value of $141.3 million for FY2024, which is 109.72% up from last year.
  • Latest data reveals that Harmony Biosciences Holdings reported Change in Cash of $100.9 million as of Q3 2025, which was up 76.94% from $57.1 million recorded in Q2 2025.
  • Over the past 5 years, Harmony Biosciences Holdings' Change in Cash peaked at $100.9 million during Q3 2025, and registered a low of -$87.5 million during Q1 2021.
  • For the 3-year period, Harmony Biosciences Holdings' Change in Cash averaged around $36.6 million, with its median value being $36.0 million (2025).
  • Per our database at Business Quant, Harmony Biosciences Holdings' Change in Cash crashed by 285.85% in 2021 and then spiked by 874.83% in 2024.
  • Harmony Biosciences Holdings' Change in Cash (Quarterly) stood at $44.6 million in 2021, then crashed by 139.37% to -$17.6 million in 2022, then grew by 26.40% to -$12.9 million in 2023, then surged by 607.89% to $65.6 million in 2024, then soared by 44.07% to $100.9 million in 2025.
  • Its Change in Cash stands at $100.9 million for Q3 2025, versus $57.1 million for Q2 2025 and $36.0 million for Q1 2025.